| 促红细胞生成素及其受体与肿瘤性贫血的研究 |
| |
| 引用本文： | 冯玫,马沐雅.促红细胞生成素及其受体与肿瘤性贫血的研究[J].白血病．淋巴瘤,2008,17(3):231-233. |
| |
| 作者姓名： | 冯玫 马沐雅 |
| |
| 作者单位： | 山西省人民医院血液风湿科,太原,030012;山西省人民医院血液风湿科,太原,030012 |
| |
| 摘 要： | 慢性疾病性贫血（ACD）是指与慢性感染、炎症、肿瘤有关的一类贫血综合征，恶性肿瘤患者常出现贫血。近年来重组人促红细胞生成素（rhEPO），广泛用于贫血临床治疗方面，尤其在肿瘤相关性贫血的治疗方面取得显著成果，避免了输血带来的诸多不良反应，提高了患者的生存质量，成为防治化疗引起贫血的重要选择。因此，rhEPO对肿瘤相关性贫血的治疗机制也成为研究热点。
|
| 关 键 词： | 红细胞生成素 重组 贫血 |
| 收稿时间： | 2007-12-01; |
Research on ereythropoietin and its receptor in anemia of neoplasm |
| |
| FENG Mei,MA Mu-ya.Research on ereythropoietin and its receptor in anemia of neoplasm[J].Journal of Leukemia & Lymphoma,2008,17(3):231-233. |
| |
| Authors: | FENG Mei MA Mu-ya |
| |
| Institution: | FENG Mei, MA Mu-ya (Department of Hematology and Rheumatism, Shanxi Provicial People＇s Hospital, Taiyuan 030012, China) |
| |
| Abstract: | The anemia of chronic disease is chronic infection, inflammation, a class of cancer-related anemia syndrome, anemia in patients with malignant tumors often. In recent years recombinant human erythropoietin, widely used in clinical treatment of anemia, Especially in cancer-related anemia treatment achieved remarkable results, a blood transfusion to avoid the many adverse effects and improve the patient' s quality of life. A control chemotherapy-induced anemia is an important choice. Therefore, rhEPO on cancer-related anemia treatment mechanism has also become a research hotspot. |
| |
| Keywords: | Erythropoietin Erythmpoietin recombinant Anemia |
| 本文献已被 维普 万方数据 等数据库收录！ |
| 点击此处可从《白血病．淋巴瘤》浏览原始摘要信息 |
| 点击此处可从《白血病．淋巴瘤》下载免费的PDF全文 |
|
